Mounjaro® (Tirzepatide) weight loss prescription asthma until the packet is finished
Mounjaro® (Tirzepatide) weight loss prescription asthma until the packet is finishedWhat is Mounjaro (Tirzepatide)? Mounjaro contains tirzepatide, the first medicine to activate both the GIP and GLP 1 receptors. It was authorised in the EU in 2022, got approved in the UK in November 23, and can now be prescribed for weight loss in Ireland. See your other weight loss options. Who is eligible for Mounjaro? You may be suitable if you: have a BMI of 30 or above have a BMI of 27 or above and at least one weight related problem (this could
Pay in 4 interest-free payments of $5.38 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3